WA
REGN icon

WPG Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

WPG Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Hold
33
– – 0.01% 547
2026
Q1 		$25.5K Hold
33
– – 0.02% 422
2025
Q4 		$25.5K Buy
33
+25
+313% +$17K 0.02% 451
2025
Q3 		$4.5K Buy
8
+1
+14% +$565 ﹤0.01% 937
2025
Q2 		$3.67K Buy
7
+4
+133% +$2.23K ﹤0.01% 976
2025
Q1 		$1.9K Buy
3
+1
+50% +$688 ﹤0.01% 1126
2024
Q4 		$1.43K Buy
+2
New +$1.68K ﹤0.01% 1165

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

WPG Advisers's REGN Position: Q2 2026 in Review

WPG Advisers held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 33 shares worth $20.6K. The position accounts for 0.01% of the portfolio, ranked #547.

WPG Advisers first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.5K in Q1 2026. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • WPG Advisers held 33 shares of Regeneron Pharmaceuticals worth $20.6K as of Q2 2026.
  • WPG Advisers left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #547 holding.
  • WPG Advisers first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Regeneron Pharmaceuticals position peaked at $25.5K in Q1 2026.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.